Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of ERCC2 gene polymorphisms on the treatment outcome of osteosarcoma.

Genetics and molecular research : GMR - 21 Oct 2015

Liu Z F, Asila A L J, Aikenmu K, Zhao J, Meng Q C, Fang R

Abstract excerpt

We conducted a prospective study to investigate the role of ERCC2 gene polymorphisms on the outcome of cisplatin-based treatment in patients with osteosarcoma. A total of 115 patients with osteosarcoma were included in our study. Genotyping of ERCC2 Asn312Asp (rs1799793) and Lys751Gln (rs13181) was performed using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry method. Of the 115...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Agents

Share to Cisplatin

Share to Genotype

Share to Osteosarcoma

Share to Polymorphism, Single Nucleotide

Share to Treatment Outcome

Share to Xeroderma Pigmentosum Group D Protein

Share to Young Adult

Source

Identifiers

PMID: 26505449
DOI: 10.4238/2015.October.21.17

Genes

ERCC2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of ERCC2 gene polymorphisms on the treatment outcome of osteosarcoma.PMID 26505449Read ↗

Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma.Semantic proximity Read ↗

Letter regarding Li JS et al. entitled "ERCC polymorphisms and prognosis of patients with osteosarcoma".Semantic proximity Read ↗

Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma.Semantic proximity Read ↗

Association of ERCC gene polymorphism with osteosarcoma risk.Semantic proximity Read ↗

Association of four ERCC1 and ERCC2 SNPs with survival of bone tumour patients.Semantic proximity Read ↗

Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosisSemantic proximity Read ↗

The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.Semantic proximity Read ↗

Genetic variability of DNA repair mechanisms and glutathione-S-transferase genes influences treatment outcome in osteosarcoma.Semantic proximity Read ↗

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.Semantic proximity Read ↗

Role of ERCC2 and ERCC3 gene polymorphisms in the development of osteosarcoma.Semantic proximity Read ↗

ERCC polymorphisms and prognosis of patients with osteosarcoma.Semantic proximity Read ↗

Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.